Show simple item record

dc.contributor.authorMorris, Karen
dc.contributor.authorTugwood, Jonathan D
dc.contributor.authorKhoja, Leila
dc.contributor.authorLancashire, Matthew
dc.contributor.authorSloane, Robert
dc.contributor.authorBurt, Deborah J
dc.contributor.authorShenjere, Patrick
dc.contributor.authorZhou, Cong
dc.contributor.authorHodgson, C
dc.contributor.authorOhtomo, T
dc.contributor.authorKatoh, A
dc.contributor.authorIshiguro, T
dc.contributor.authorValle, Juan W
dc.contributor.authorDive, Caroline
dc.date.accessioned2014-09-04T09:08:25Zen
dc.date.available2014-09-04T09:08:25Zen
dc.date.issued2014-08en
dc.identifier.citationCirculating biomarkers in hepatocellular carcinoma. 2014, 74 (2):323-32 Cancer Chemother Pharmacolen
dc.identifier.issn1432-0843en
dc.identifier.pmid24923562en
dc.identifier.doi10.1007/s00280-014-2508-7en
dc.identifier.urihttp://hdl.handle.net/10541/325864en
dc.description.abstractOur aims are to determine levels of circulating cellular and protein biomarkers in hepatocellular carcinoma (HCC) patients and to analyse any relationships with clinical parameters.
dc.language.isoenen
dc.rightsArchived with thanks to Cancer chemotherapy and pharmacologyen
dc.titleCirculating biomarkers in hepatocellular carcinoma.en
dc.typeArticleen
dc.contributor.departmentClinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute, University of Manchester, Manchester, UK.en
dc.identifier.journalCancer Chemotherapy and Pharmacologyen
html.description.abstractOur aims are to determine levels of circulating cellular and protein biomarkers in hepatocellular carcinoma (HCC) patients and to analyse any relationships with clinical parameters.


This item appears in the following Collection(s)

Show simple item record